Cargando…
A Neuroendocrine Tumor Specialty Center in New Orleans’ (NOLANETS) Response to Patient Care During the COVID‐19 Pandemic
This commentary outlines the steps taken by the New Orleans Louisiana Neuroendocrine Tumor Specialists to minimize the risk of patient exposure to SARS‐CoV‐2 but to continue to provide safe, high‐quality care during the COVID‐19 pandemic.
Autores principales: | Ramirez, Robert A., Bren‐Mattison, Yvette, Thiagarajan, Ramcharan, Boudreaux, J. Philip, Marsala, Andrew J., Ryan, Pamela, Maluccio, Mary A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356714/ https://www.ncbi.nlm.nih.gov/pubmed/32369669 http://dx.doi.org/10.1634/theoncologist.2020-0279 |
Ejemplares similares
-
A Peptide Meets a Radionuclide to Combat a Rare Tumor
por: Thomas, Katharine E., et al.
Publicado: (2021) -
Adjuvant therapy for lung neuroendocrine neoplasms
por: Ramirez, Robert A, et al.
Publicado: (2021) -
Outcomes of Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs)
por: Thomas, Katharine, et al.
Publicado: (2020) -
Detection of pancreatic cancer by indocyanine green‐assisted fluorescence imaging in the first and second near‐infrared windows
por: Li, Zhongqiang, et al.
Publicado: (2021) -
Specialty services offered by pharmacists in the community
por: Morreale, Anthony P., et al.
Publicado: (2019)